March 21st 2025, 7:00pm
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
March 20th 2025, 9:00pm
Dr. Sara M. Tolaney discussed HER2-positive breast cancer, highlighting key trials, evolving treatment strategies, and the potential for improved outcomes.
March 20th 2025, 8:00pm
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
March 20th 2025, 7:05pm
Itovebi, approved for some patients with breast cancer, is the first PI3K inhibitor to display a survival benefit, according to Dr. Kevin Kalinsky.
March 19th 2025, 9:00pm
Gene expression testing helps determine chemotherapy needs for HR+ breast cancer, optimizing treatment and reducing unnecessary toxicity.
March 18th 2025, 8:01pm
Genetic and genomic testing guide breast cancer risk assessment and treatment, as discussed by Dr. Mark Robson at the Miami Breast Cancer Summit.
March 18th 2025, 1:00pm
Dr. Debu Tripathy discusses recent research on the use of circulating tumor DNA in metastatic breast cancer care.
March 16th 2025, 2:00pm
CURE spoke with Kelly Grosklags of Conversations With Kelly at the Miami Breast Cancer Conference.
March 15th 2025, 6:00pm
Dr. Kevin Kalinsky covers the gamut of the current treatment landscape for patients with HER2-negative breast cancer, highlighting recent advancements.
March 12th 2025, 3:00pm
Dr. Kandace P. McGuire discusses how targeted axillary staging differs from traditional methods of staging in patients undergoing breast cancer treatment.
This Wasn't the Plan: The Truth
Living With Intention After a Cancer Diagnosis
June Lung Cancer Highlights: Top 5 Updates Patients Should Know
Could Shedding a Few Pounds Prevent a Breast Cancer Recurrence?